Middle East & Africa Influenza Drug Market to 2032
Overview
The Middle East & Africa Influenza Drug Market is expected to reach a 1,341.13 USD Million by 2032 and is projected to grow at a CAGR of 6.25% from 2025 to 2032.
Revenue, 2024 (USD Million)
906.30
Forecast, 2032 (USD Million)
1,341.13
CAGR, 2024 - 2032
6.25%
Report Coverage
Middle East & Africa
Middle East & Africa Influenza Drug Market 2018-2032 USD Million
Middle East & Africa Influenza Drug Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 906.30 USD Million
- Projected Market Size (2032): 1,341.13 USD Million
- CAGR (2025-2032): 6.25%
Key Findings of Middle East & Africa Influenza Drug Market
- The Middle East & Africa Influenza Drug Market was valued at 906.30 USD Million in 2024.
- The Middle East & Africa Influenza Drug Market is likely to grow at a CAGR of 6.25% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 1,569.94 USD Million
- The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 7.12% during the forecast period from 2024 to 2032.
Middle East & Africa Influenza Drug Market Scope
Middle East & Africa Influenza Drug Market Segmentation & Scope
Type
- Influenza C
- Influenza B
- Influenza A
Treatment
- Drugs
- Vaccines
Route of Administration
- Intravenous
- Intranasal
- Intradermal
- Intramuscular
- Oral
Age
- Pediatrics
- Adults
End User
- Homecare
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Middle East & Africa Influenza Drug Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 906.30 USD Million |
| Market Value in 2032 | 1,341.13 USD Million |
| CAGR (2025-2032) | 6.25% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Treatment,Route of Administration,Age,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 906.30 USD Million in 2024
- Key Country: South Africa, leading in terms of revenue with value of 312.94 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Influenza Drug Market to 2032, By Type
- Influenza A is the largest segment in Middle East & Africa Influenza Drug Market to 2032 with a revenue of 412.52 USD Million in the year 2024.
- Influenza A is the Fastest growing segment in Middle East & Africa Influenza Drug Market to 2032 with a Growth rate of 6.81 % in forecast period 2025-2032.
-
Middle East & Africa Influenza Drug Market to 2032, By Treatment
- Vaccines is the largest segment in Middle East & Africa Influenza Drug Market to 2032 with a revenue of 1.57 USD Million in the year 2024.
- Vaccines is the Fastest growing segment in Middle East & Africa Influenza Drug Market to 2032 with a Growth rate of 6.28 % in forecast period 2025-2032.
-
Middle East & Africa Influenza Drug Market to 2032, By Route of Administration
- Oral is the largest segment in Middle East & Africa Influenza Drug Market to 2032 with a revenue of 376.71 USD Million in the year 2024.
- Oral is the Fastest growing segment in Middle East & Africa Influenza Drug Market to 2032 with a Growth rate of 7.12 % in forecast period 2025-2032.
-
Middle East & Africa Influenza Drug Market to 2032, By Age
- Adults is the largest segment in Middle East & Africa Influenza Drug Market to 2032 with a revenue of 465.36 USD Million in the year 2024.
- Pediatrics is the Fastest growing segment in Middle East & Africa Influenza Drug Market to 2032 with a Growth rate of 5.77 % in forecast period 2025-2032.
-
Middle East & Africa Influenza Drug Market to 2032, By End User
- Hospitals is the largest segment in Middle East & Africa Influenza Drug Market to 2032 with a revenue of 648.62 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Middle East & Africa Influenza Drug Market to 2032 with a Growth rate of 6.43 % in forecast period 2025-2032.
-
Middle East & Africa Influenza Drug Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Middle East & Africa Influenza Drug Market to 2032 with a revenue of 492.65 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Middle East & Africa Influenza Drug Market to 2032 with a Growth rate of 6.61 % in forecast period 2025-2032.
Middle East & Africa Influenza Drug Market Company Share Analysis
| Company Name |
|
||
| Sanofi | |||
| AstraZeneca | |||
| GSK plc. | |||
| CSL | |||
| F. Hoffmann-La Roche Ltd. | |||
Middle East & Africa Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million
Middle East & Africa Influenza Drug Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Influenza Drug Market is segmented based on Segmentation Type,Treatment,Route of Administration,Age,End User,Distribution Channel.
Middle East & Africa Influenza Drug Market was valued at USD 906.30(Revenue in USD Million) in 2022.
Middle East & Africa Influenza Drug Market is projected to grow at a CAGR of 6.25% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the Middle East & Africa Influenza Drug Market, holding a largest market share of 1,569.94 USD Million in 2024
Middle East & Africa Influenza Drug Market Scope
Middle East & Africa Influenza Drug Market Segmentation & Scope
Type
- Influenza C
- Influenza B
- Influenza A
Treatment
- Drugs
- Vaccines
Route of Administration
- Intravenous
- Intranasal
- Intradermal
- Intramuscular
- Oral
Age
- Pediatrics
- Adults
End User
- Homecare
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Frequently Asked Questions
The Middle East & Africa Influenza Drug Market is segmented based on Segmentation Type,Treatment,Route of Administration,Age,End User,Distribution Channel.
Middle East & Africa Influenza Drug Market was valued at USD 906.30(Revenue in USD Million) in 2022.
Middle East & Africa Influenza Drug Market is projected to grow at a CAGR of 6.25% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Influenza Drug Market for final year is USD 1,341.13 (USD Million).
Middle East & Africa Influenza Drug Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Influenza Drug Market is segmented based on Segmentation Type,Treatment,Route of Administration,Age,End User,Distribution Channel.
Middle East & Africa Influenza Drug Market was valued at USD 906.30(Revenue in USD Million) in 2022.
Middle East & Africa Influenza Drug Market is projected to grow at a CAGR of 6.25% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Influenza Drug Market for final year is USD 1,341.13 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.